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Abstract
Since their isolation until implantation, pancreatic islets suffer a major stress leading to the activation of inflammatory
reactions. The maintenance of controlled inflammation is essential to preserve survival and function of the graft.
Identification and targeting of pathway(s) implicated in post-transplant detrimental inflammatory events, is mandatory to
improve islet transplantation success. We sought to characterize the expression of the pro-inflammatory and pro-oxidant
mediators during islet culture with a focus on Heme oxygenase (HO-1) and Toll-like receptors-4 signaling pathways. Rat
pancreatic islets were isolated and pro-inflammatory and pro-oxidant status were evaluated after 0, 12, 24 and 48 hours of
culture through TLR-4, HO-1 and cyclooxygenase-2 (COX-2) expression, CCL-2 and IL-6 secretion, ROS (Reactive Oxygen
Species) production (Dihydroethidine staining, DHE) and macrophages migration. To identify the therapeutic target, TLR4
inhibition (CLI-095) and HO-1 activation (cobalt protoporphyrin,CoPP) was performed. Activation of NFkB signaling pathway
was also investigated. After isolation and during culture, pancreatic islet exhibited a proinflammatory and prooxidant status
(increase levels of TLR-4, COX-2, CCL-2, IL-6, and ROS). Activation of HO-1 or inhibition of TLR-4 decreased inflammatory
status and oxidative stress of islets. Moreover, the overexpression of HO-1 induced NFkB phosphorylation while the
inhibition of TLR-4 had no effect NFkB activation. Finally, inhibition of pro-inflammatory pathway induced a reduction of
macrophages migration. These data demonstrated that the TLR-4 signaling pathway is implicated in early inflammatory
events leading to a pro-inflammatory and pro-oxidant status of islets in vitro. Moreover, these results provide the
mechanism whereby the benefits of HO-1 target in TLR-4 signaling pathway. HO-1 could be then an interesting target to
protect islets before transplantation.
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Introduction
Pancreatic islet transplantation is a non-invasive therapeutic
option to replace the b-cell mass in type 1 diabetic patients with
marked glycemic variability and/or severe and recurrent hypo-
glycemic episode [1–4]. During the last decade, important
progress has been made in islet transplantation in clinical practice
[5–7]. The Edmonton protocol has greatly increased the survival
and initial function of transplanted islets. Significant improvement
has occurred in the outcomes of clinical islet transplantation
reflecting improvements in immunosuppression, and preparation
of sufficient quantities of highly viable islets for transplantation
[5,8–10].
However, transplanted islets are particularly vulnerable in the
first days after transplantation [11]. More than 50% of islets fail to
engraft at this early phase, representing a major impediment for
successful islet transplantation [12]. Moreover, even in optimal
conditions, approximately 60% of transplanted syngeneic islet
tissue is lost 3 days after transplantation [13]. Then, early graft loss
in islet transplantation requires large amount of donors islets.
[14,15]. An early innate inflammatory reaction at the grafted site
may be partly related to damage to islets during isolation [16] and
strongly affects islet engraftment and survival after intrahepatic
transplantation. This early reaction is triggered by ischemia-
reperfusion injury and instant blood mediated inflammatory
reaction (IBMIR) occurring hours and days after islet infusion.
Evidence in both mouse model and in human counterpart suggests
the involvement of coagulation, complement system, and proin-
flammatory chemokines/cytokines but macrophage mediated non
specific inflammatory reaction could also contributes significantly
to early dysfunction of islets grafts [8]. Mechanisms underlying
early islet loss following transplantation remain poorly defined but
apoptotic islet cell death associated with peri and intra-islet graft
inflammation have been described [17,18]. The process of
isolation exposes islets to a number of stresses that can adversely
affect cell survival [19]. Experiments suggest that islet isolation and
culture induced a general inflammatory response [20]. The
isolation procedure confers then a pro-inflammatory and pro-
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oxydant status of islets. In response, islets expressed a panel of pro-
inflammatory mediators such as CCL2, IL-6, TNF-a [21]. CCL-2
is constitutively present in normal human islet cells, in the absence
of an inflammatory infiltrate and CCL-2 secretion resulted as the
more relevant factor for successful engraftment and long-lasting
insulin independence. However, CCL-2 production by pancreatic
islets is strongly increased by inflammatory cytokines, suggesting a
possible involvement of this chemokine in the early inflammatory
response [22]. Islet CCL2 release seems to be a sign of
‘‘inflammed’’ islets and a causal effect for developing detrimental
proinflammatory conditions after transplant [23,24]. In contrast,
IL-6, TNF-a can stimulate the expression of cyclooxygenase-2
(COX-2), which is believed to be mediator of cytokine-induced
islet damage [25,26].
Moreover, Toll-like receptors (TLRs) transmitted signals
activate innate immunity by inducing chemokine and cytokine
release and through upregulating costimulatory molecule expres-
sion, among a multitude of other effects [27]. Recent studies
revealed the importance of islet expressed TLRs, particularly
TLR2 and TLR4, participating in the pathogenesis of autoim-
mune diabetes and allogeneic islet transplant rejection [28–
30].TLR2 or TLR4 initiated a proinflammatory milieu, likely
via chemokines and cytokine release at the graft site, associated
with graft apoptosis and early graft [31]. TLR transmitted signals
in the islets impact early islet engraftment has not been studied.
However, a relationship between TLR and Heme oxygenase-1
(HO-1; heat shock protein hsp32) signaling pathway is established
in hepatic ischemia-reperfusion injuries [32], and it is demon-
strated that induction of HO-1 attenuates lipopolysaccharide-
induced cyclooxygenase-2 expression in mouse brain endothelial
cells [11]. In fact, HO-1 is among the most critical protective
mechanisms activated during cellular stress, and it is thought to
play a key role in maintaining anti-oxydant/oxidant imbalance
[33]. Indeed, induction of HO-1 extends graft survival when islets
are transplanted into the kidney capsule [8,19]. Moreover, HO-1
decreases cytokine release and macrophage recruitment during the
peri-transplant period [21].
Then, identification and targeting of pathway(s), playing a role
as ‘‘master regulator(s)’’ in post-transplant detrimental inflamma-
tory events, is now mandatory to improve islet transplantation
success.
In this study, we hypothesized that the well-known benefits
induce by HO-1 are due to the inhibition of the TLR-4 signaling
pathway. To address this hypothesis, we first characterized the
expression of the pro-inflammatory and anti-inflammatory medi-
ators during islet culture. We next assessed the role of HO-1 and
TLR-4 in pro-inflammatory status of islets and validate the
consequence on macrophage migration.
Materials and Methods
Animals
Experiments were performed in accordance with the principles
and guidelines of the French legislation on animal welfare (nu
2013-118) and in the strict accordance with the recommendations
in the guide for the Care and Use of Laboratory Animals of the
Nationals Institutes of Health. The protocol was approved by the
Institutional Animal Care and Use Committee CREMEAS
(nuAL/06/35/12/12). Wistar rats (250–300 g) were purchased
from Depre´ Breeding (Elevage Depre´,St Doulchar, France). Rats
were housed in standard collective cages, in a temperature-
controlled room (2261uC) with a 12 h light/12 h darkness cycle.
They were fed with SAFE-A04 (Villemoisson-sur-Orge, France).
Food and water were available ad libitum. All surgery was
performed under anesthesia induced by intraperitoneal injection
at the dose of 100 mL/100 g of body weight of Imalgene
(Ketamine, Merial, Lyon, France) supplemented with 2.7 mL
Rompun (Xylazine 2%, Bayer, Puteaux, France). and all efforts
were made to minimize suffering.
Peritoneal macrophages culture
A chemical peritonitis was induced by an intra-peritoneal
infusion with 3% thioglycolate (Sigma-Aldrich, St Quentin
Fallavier, France) solution. Sampling was realized 72 h after
injection. Peritoneal cells were collected after laparotomy, by flush
out of rat peritoneal cavity with PBS without Ca2+ or Mg2+
(Fisher-Scientific, Illkirch, France) and plated in M199 culture
medium (Fisher-Scientific) supplemented with 1% AB/AM
(antibiotic/antimycotic) (Fisher-Scientific) and 10% FBS (Sigma-
Aldrich). After 4 hours of incubation at 37uC with 5% CO2,
nonadherent cells were removed and adherent macrophages were
incubated with addition of fresh media [34].
Islet culture
Rat islets were isolated using collagenase digestion and
purification as previously described [35]. Islets were maintained
in M199 culture medium supplemented with 1% Antibiotic/
Antimycotic and 10% FBS at 37uC with 5% CO2. To study the
pro-inflammatory and pro-oxidant status of islets, the experiments
were performed directly after islet isolation (TO), or after 12H,
24H or 48H of culture.
Peptides and inhibitors
Protoporphyrin IX cobalt chloride (C34H32CoN4O4Cl; CoPP;
Sigma-Aldrich) was dissolved NaOH 0,1 mol/L and diluted to
half in PBS. Finally, the pH was adjusted to 7.4 and the solution
was sterilized by filtration. Stimulation of TLR-4 was done with
50 ng/mL lipopolysaccharide (LPS) during 24 h served as positive
control. The working solution at 100 mmol/L was diluted in
culture medium. CLI-095 at 1 mg/ml (C15H17CIFNO4S;
InvivoGen, Toulouse, France) was dissolved in dimethylsulfoxide
(DMSO, Sigma-Aldrich) and islets were treated with 1 mmole/L of
CLI-095 diluted in culture medium. Islets were incubated during
24 h with the molecules immediately after isolation.
Islet functionality
Forty islets from each experimental condition were washed
extensively and incubated in Krebs Ringer bicarbonate (KRB)
solution with 10% FCS (Foetal Calf Serum) and 4.4 mmol/L
glucose (Sigma). Islets were then stimulated with KRB solution
containing 10% FCS and 22.6 mmol/L glucose, and to finish in
4.4 mmol/L again. Each incubation step was performed for
90 min at 37uC in humidified air with 5% CO2. Supernatants
were collected after each incubation time and stored at 280uC.
Insulin measurements were performed using a rat insulin enzyme
linked immunosorbent assay (ELISA) kit (Mercodia, Uppsala,
Sweden). The results were expressed in mg/g of total protein.
Chemotaxis assay
The chemotactic response of macrophages to rat islet superna-
tants was evaluated using a modified Boyden chamber according
to Sigrist et al. [36]. The response was defined as the mean
number of macrophages migrating and expressed in terms of
migration index defined as the following ratio: number of
macrophages attracted by the test solution (fMLP (Sigma) or
culture medium conditioned by islets with or without chemoat-
tractant)/number of macrophages attracted by the culture
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medium. Macrophage migration induced by culture medium was
considered as random migration and was used as a negative
control.
ROS analysis
The oxidative fluorescent dye dihydroethidine (DHE, Sigma-
Aldrich) was used to evaluate in situ formation of ROS by a
method described by Dal-Ros et al. [37]. Unfixed pancreatic islets
were cut into 4 mm-thick sections, treated with DHE (2.5 mM),
incubated in a light protected humidified chamber at 37uC for
30 minutes. The level of ROS was determined using microscope
and whole fluorescence of islets was quantified with the
microscope software (NIS-Elements BR, Nikon Instruments Inc.,
Champigny-sur-Marne, France). The fluorescence intensity of the
islets was quantified in fifteen arbitrarily selected islets and the
mean value for each islet was calculated.
qRT-PCR
mRNA was extracted from islets with RNeasy Plus Mini Kit
and cDNA was synthesized using 500 ng RNA and a RT2 First
Strand Kit, according to the manufacturer’s instructions (Qiagen,
Courtaboeuf, France). qRT-PCR was performed using Quanti-
Tect SYBR Green PCR (Qiagen), and reactions were run on a My
IQ 5 system (Bio-Rad, Marne la coquette, France). All primer
sequences and cycle protocols were obtained from Qiagen.
References were as follows (all rat specific): Ho-1
(Rn_Hmox1_1_SG QuantiTect Primer Assay, QT00175994);
Cox-2 (Rn_Ptgs2_1_SG QuantiTect Primer Assay,
QT00192934); Ccl2 (Rn_Ccl2_1_SG QuantiTect Primer Assay,
QT00183253); Il-6 (Rn_Il6_1_SG QuantiTect Primer Assay,
QT00182896); Il-10 (Rn_Il10_1_SG QuantiTect Primer Assay,
QT00177618); Actin (Rn_Actb_1_SG QuantiTect Primer Assay,
QT00193473); Rnr1 (Rn_Rnr1_1_SG QuantiTect Primer Assay,
QT00199374) and Rplp1 (Rn_Rplp1_2_SG QuantiTect Primer
Assay). Differential expression was determined by the 2-DDCT
method [38] using three internal controls Actin, Rplp1 and Rnr1.
Western Blot analysis
Total proteins extracts (20–40 mg) were separated on 4–12%
Bis-Tris CriterionTM XT Precast Gel (Bio-Rad, Marne-La-
Coquette, France) and transferred to an Immobilon PVDF
membrane (Millipore, Molsheim, France). TLR-4 (mouse, 1/
500; Abcam, Paris, France), HO-1-rabbit (rabbit, 1:250; Abcam),
COX-2 (rabbit, 1:1 000; Abcam), NF-kB p65 (rabbit, 1:5000; Cell
Signaling, Danvers, USA), phospho-NF-kB p65 (Ser536, mouse,
1:5000; Cell signaling) and b-actin (1:8 000) primary antibodies
(Abcam, Paris, France) were incubated overnight at 4uC. Anti-
mouse or anti-rabbit (1/8 000, Sigma-Aldrich) horseradish per-
oxidase (HRP)-conjugated secondary antibody was incubated for
1 h at room temperature and developed by the LuminataTM
Forte Western HRP substrate (Millipore, Molsheim, France) with
Chemidoc XRS (Bio-Rad, Marne-La-Coquette, France).
Cytokine and chemokine analyses
Islets supernatant were stored at 280uC prior to analysis.
CCL2, IL-6 and IL-10 levels were determined by ELISA (R&D
systems or Raybiotec, Inc., Clinisciences, Nanterre, France),
according to the manufacturer’s instructions.
Endotoxin measurement
Endotoxin levels were determined on the culture medium of
pancreatic islets by Limulus Amebocyte Lysate assay (Lonza,
Verviers, Belgium).
Statistical analysis
Data were expressed as mean 6 SEM of the number of
replicates. Differences between two groups were evaluated with t-
test. Differences among three or more groups were evaluated using
the nonparametric one-way ANOVA test with a Newman-Keuls
multiple comparison post-test. Differences were considered signif-
icant when p,0.05.
Results
Islets isolation and culture exacerbate its pro-
inflammatory and pro-oxidant status
Previous work showed that an inflammatory phenotype is a
common feature of grafts in cell transplantation and can
exacerbate deleterious pro-inflammatory response after transplan-
tation [39]; however, the contribution of in vitro pre-transplan-
tation process is well known but poorly described in the occurrence
of the inflammatory phenotype. Therefore, we investigated the
mRNA and protein expression of inflammatory markers on rat
pancreatic islets directly after islet isolation and during 48 h of
culture (Fig. 1). For each mediator, mRNA and protein expression
were very well correlated. The maximum of expression of TLR-4
was obtained immediately after isolation but significantly de-
creased after 12 h (4765%; p,0.05). This expression was
maintained at a comparable level after 24 h and 48 h of culture
(Fig. 1A). Expression of COX-2, a downstream mediator of the
TLR-4 signaling pathway, was very low immediately after
isolation. However, the expression was significantly increased
after 12 h (p,0.001) but diminished progressively until 48 h (p,
0.001) (Fig. 1B). We explored further the cytokine profile of islets
in vitro, in particular IL-6 and CCL2, two major components
involved in the islet inflammatory response [23,39]. Similar to
COX-2, IL-6 (Fig. 1C) and CCL2 (Fig. 1D) were highly released
after 12 h of islet culture. This maximum amount was followed by
a progressive and significant decrease of CCL-2 and IL-6 release
(IL-6: 720.6 pg/mL673.6 versus 398.1 pg/mL621.6; CCL2:
11270.66425.3 versus 7584.7 pg/mL6489.9).
To determine which mechanisms of defense are used by islets to
protect against inflammation, we focused on HO-1 expression and
IL-10 release (fig. 2). HO-1 has been demonstrated to be
protective for islet by its anti-inflammatory, anti-oxidant, anti-
apoptotic properties [40,41]. On the other hand, IL-10 is an anti-
inflammatory cytokine which limits the inflammatory response
[42]. HO-1 was weakly expressed after isolation but significantly
increased until 48 h to reach 227.7%65.9 (fig. 2A). We observed
also an increase of IL-10 during the time of culture, but the IL-10
levels remained very low. Undetectable immediately after trans-
plantation, IL-10 secretion reached 5.3 pg/ml60.4 after 48 h of
culture (fig. 2B).
Previous data have established the link between inflammation
and ROS production [43]. As a mediator of inflammation, we
examined the evolution and the source of ROS during 48 h of islet
culture. ROS were produced at high levels immediately after
isolation, whereas during culture the production was significantly
lowered (72.6%62.7 at 48 h; p,0.05) (Fig. 2C,D).
Islet pro-inflammatory/pro-oxidant status is TLR-4
dependent and can be limited by HO-1
To investigate whether TLR4 signaling pathways are involved
in the inflammatory process in vitro, we treated islets in culture
with an inhibitor of TLR4, CLI-095 [44,45]. Indeed, previous
work showed that islet-expressed TLR2 and TLR4 sense injury
and mediate early graft failure after transplantation [31]. Given
that HO-1 overexpression is known to improve islet transplanta-
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tion [46–48] and limit the TLR signaling pathway [49,50], we also
wanted to highlight that the inflammation of islet in vitro is TLR-4
dependent but also that HO-1 can prevent this process by
inhibiting TLR pathway activation.
Given that CoPP is known to up-regulate HO-1 expression
[41,51], we assessed whether CoPP could induce Ho-1 activation
in islets. Thus, we demonstrated that CoPP alone was a powerful
activator of Ho-1 (Fig. 3A) (549%649; p,0.001), but co-
treatment of islets with CoPP and the TLR-inhibitor CLI-095
also significantly increased Ho-1 activation compared to the
control.
Concerning the effect of Ho-1 up-regulation on Cox-2 pathway,
we observed that CoPP induced a significant decrease in Cox-2
expression (35.5%62.6; p,0.001). We also found that CLI-095
treatment decreased Cox-2 expression (61.961.1; p,0.001)
(Fig. 3B). The co-administration of CoPP and CLI-095 induced
a greater decrease of COX-2 expression compared to the
treatment with CLI-095 alone (61.9%61.1 versus 16.8%62.5;
p,0.001).
Finally, ROS production of islets was significantly inhibited with
CoPP or CLI-095 alone and co-administration of both agents
improved again this inhibition (Fig. 3C).
Expression of Cox-2 is regulated by several transcription factors
including nuclear NFkB [52]. Moreover, TLR4-mediated activa-
tion of the NFkB-pathway and thereby the production of IL-6
[53]. To investigate the pro-inflammatory signaling pathway
involvement, we studied then the activation of NFkB(Fig. 3D).
Surprisingly, CoPP induced a significant increase of NFkB
phosphorylation in comparison to control islet (p,0.001).
Inhibition of TLR-4 on islet alone had no effect on NFkB
activation. However, co-administration of CoPP and CLI-095
significantly decreased the NFkB activation induced by CoPP (p,
0.001).
To confirm that islet function was not affected by the
suppression of pro-inflammatory and pro-oxidant status using
CLI-095 or CoPP, we studied glucose stimulation insulin released
by islets. Islet functionality was maintained in basal and stimulated
conditions in presence of CoPP or/and CLI-095 (figure 4).
TLR-4 activation is inhibited by HO-1
To establish the relationship between TLR-4 and HO-1, we
determined the effect of HO-1 induction on LPS-mediated TLR-4
activation (Fig. 5). TLR-4 activation on pancreatic islets using LPS
induced a significant increase of Cox-2 expression (Fig. 5A). This
increase of Cox-2 expression was associated with an increase of IL-
Figure 1. Pro-inflammatory status of pancreatic islets after isolation. Islets were incubated in M199 culture medium for 0, 12,24 and 48 h.
(A,B) Gene expression of Tlr-4, Cox-2 was evaluated by qRT-PCR and protein expression of TLR-4 and COX-2 were analyzed by Western blotting. (C,D)
CCL2 and IL-6 release in supernatant were evaluated by ELISA. Data shown are mean 6 SEM and are representative of at least three independent
experiments. *p,0.05, compared to T0, when T0 was not available (N/A) it is compared to T12H or brackets show the compared values.
doi:10.1371/journal.pone.0107656.g001
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6 secretion (Fig. 5B). As previously shown figure 3, induction of
HO-1 using CoPP alone on islet decreased Cox-2 expression and
IL-6 secretion (p,0.001). Moreover, the pro-inflammatory status
of islet induced by LPS was significantly reduced by HO-1
activation. Cox-2 expression was decreased from 2.6 to 0.5 (p,
0.001) and IL-6 secretion from 4010 to 474 pg/mL (p,0.001).
Macrophages migration is mediated by islet pro-
inflammatory status
Macrophages are among two major cell types infiltrating islets
after transplantation [54]. In previous studies, we mimicked
macrophage infiltration in vitro in a modified Boyden’s chamber
[36,55,56] and demonstrated that pancreatic islets release
chemokines, which promote macrophage attraction, hampering
engraftment of islets [36]. We hypothesized that the release of
chemokines and cytokines by islets is affected by the treatment of
islets with TLR-inhibitors or Ho-1 inducer. To test this hypothesis,
we evaluated the effect of CoPP and CLI-095 on islet CCL-2 and
IL-6 release (Fig. 6A,B). Twenty four hours treatment of
pancreatic islets with CoPP induced a significantly decreased of
CCL2 (26,6 mg/ml63.7; versus 77.9 mg/ml63.7; p,0.01) and
IL-6 (77.9 mg/ml/ml67.2 versus 3504 mg/ml6570; p,0.01) as
compared to control condition. In the same way, TLR-4 inhibition
resulted in a decrease of CCL-2 and IL-6 secretion. Co-
administration of CoPP and CLI-095 also led to a decrease of
cytokine and chemokine secretion. To confirm these results, we
evaluated the impact of islets pretreatment on macrophages
migration induced by islet supernatant. As expected, islet
supernatant induced a massive and significant macrophage
migration compared to both controls (CTL2, culture medium
or CTL+, fMLP). However, with all pretreatments, islet culture
supernatant lost its potency to induce macrophage migration in
comparison of non-treated islet (Fig. 6C).
Discussion
Collectively, our data indicate that the TLR signaling pathway
plays an important role in the inflammatory response induced by
pre-implantation injuries of pancreatic islets. Indeed, we demon-
strated that cultured islets exhibit a pro-inflammatory and pro-
oxidant phenotype characterized by high level of pro-inflamma-
tion markers and low defense mechanisms. Inhibition of TLR-4
confirmed a partial dependence of this inflammatory process on
Figure 2. Anti-inflammatory and pro-oxidant status of pancreatic islet after isolation. Islets were incubated in M199 culture medium for 0,
12, 24 and 48 h. (A) Gene expression of Ho-1 was evaluated by qRT-PCR and protein expression of HO-1 was analyzed by Western blotting. (B) IL-10
release in supernatant was evaluated by ELISA. (C, D) ROS production was evaluated with DHE. Data shown are mean 6 SEM and are representative
of at least three independent experiments. *p,0,05; compared to T0 and N/A means that the values were not available.
doi:10.1371/journal.pone.0107656.g002
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this signaling pathway. Moreover, HO-1 over-expression prevent-
ed the pro-inflammatory and pro-oxidant phenotype.
Our observation on COX-2 overexpression and pro-inflamma-
tory cytokines release induced by islet culture is consistent with our
previous studies [57] and others [58,59]. The inducible isoform of
cyclooxygenase, COX-2, is usually expressed at low levels in most
tissues and cells, but is significantly induced by a wide range of
inflammatory stimuli such as lipopolysaccharides and cytokines
[60]. Some data demonstrated that COX-2 is overexpressed in
pancreatic islet under both basal and stimulated conditions [61].
However, Sorli et al. have also demonstrated that preactivation of
islet tissue by exposure to stimulatory agents contained in
collagenase or Ficoll during islet isolation process can not alone
explain this stimulation because identical treatment of hepatocytes
failed to induce COX-2 gene expression [61]. Heitmeier et al.
suggested that even if cytokines stimulate the expression of COX-
2, inhibition of COX-2 activity does not protect rat and human
islets from cytokine-induced beta-cell dysfunction [62]. Thus, its
deleterious role on islet inflammation remains unclear because the
success of in vitro exposure of pancreatic islets to COX-2-specific
inhibitors is well known [63]. Thereby, COX-2 expression during
culture is rather an indicator of pro-inflammatory pathway
Figure 3. Role of TLR-4 and HO-1 on islet pro-inflammatory status. Islets were incubated for 24 h with M199 culture medium (CTL), cobalt
protoporphyrin (CoPP, HO-1 inducer), CLI-095 (TLR-4 inhibitor), CoPP+CLI-095 at the same time. (A,B) HO-1 and COX-2 gene expression was analyzed
by qRT-PCR. (C, D) ROS production was assessed with DHE. Data shown are mean 6 SEM and are representative of at least three independent
experiments. *p,0.05, in comparison with CTL. #p,0.05 in comparison with CoPP, and $p,0.05 in comparison CLI-095.
doi:10.1371/journal.pone.0107656.g003
Figure 4. Measure of islet functionality. Islets were incubated for
24 h with M199 culture medium (CTL), cobalt protoporphyrin (CoPP,
HO-1 inducer), CLI-095 (TLR-4 inhibitor), CoPP+CLI-095 at the same
time. White bars: basal conditions with 4.4 mmol/L of glucose, Black
bar: stimulated conditions with 22.6 mmol/L.
doi:10.1371/journal.pone.0107656.g004
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Figure 5. Role of HO-1 activation in TLR-4 inhibition. (A,B) Islets were incubated for 24 h with M199 culture medium (CTL), LipoPolySaccharide
(LPS, TLR-4 activator), cobalt protoporphyrin (CoPP, HO-1 inducer), LPS+CoPP at the same time. (A) COX-2 gene expression was analyzed by qRT-PCR
(B) IL-6 release in supernatant was evaluated by ELISA. *p,0.05, in comparison with CTL. #p,0.05 in comparison with LPS, and $p,0.05 in
comparison CoPP.
doi:10.1371/journal.pone.0107656.g005
Figure 6. Role of TLR-4 and HO-1 on islet mediated macrophage recruitment. (A,B) Islets were incubated for 24 h with M199 culture
medium (CTL), cobalt protoporphyrin (CoPP, HO-1 inducer), CLI-095 (TLR-4 inhibitor), CoPP+CLI-095 at the same time. CCL2 and IL-6 release in
supernatant was evaluated by ELISA. (C) Islets were incubated for24 h with M199 culture medium (CLT2), cobalt protoporphyrin (CoPP, HO-1
inducer), CLI-095 (TLR-4 inhibitor) or CoPP+CLI-095 at the same time. Supernatant were then used to induce macrophage migration. fMLP (CTL+), non
treated islet supernantant (S) were used to promote positive macrophage migration. Data shown are mean 6 SEM and are representative of at least
three independent experiments. A, B, C *p,0.05, in comparison with CTL; #p,0.05 in comparison with CTL+. $p,0.05 in comparison with S.
doi:10.1371/journal.pone.0107656.g006
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activation than the direct mediator of the deleterious effect of
inflammation on islet.
Several studies have postulated that islets can contribute to their
own death after transplantation by the elaboration of inflamma-
tory factors [64]. Among the pro-inflammatory mediators released
by islets, the pro-inflammatory cytokines plays a central role in the
loss of transplanted islets by triggering their death [20]. Our results
have clearly demonstrated that CCL-2 and IL-6 are strongly up-
regulated in the first twelve hours after isolation in culture. In the
same way, several studies have established a large release of CCL-
2 [23] and IL-6 [19]. The importance of these pro-inflammatory
factors has been highlighted by the correlation between their
release and poor clinical outcome of islet transplants.
Furthermore, oxidative stress has also been demonstrated to
play a pivotal role in islet cell damage and functional impairment.
Armann et al. have demonstrated that levels of ROS in islets were
correlated with the percentage of apoptotic cells and islet
functional potency in vivo [65]. In this way, we demonstrated
that the high level of ROS in islet after isolation is clearly
correlated with the level of pro-inflammatory factors. Moreover,
we have to keep in mind that anti-oxidative defense mechanisms in
islets are very low [66] and between different species the activities
of antioxidant enzymes can also vary substantially. Welsh et al.
have shown that human islets have more active catalase and SOD
than rodents and, consequently, are more resistant to oxidative
stress [67]. Moreover, it has been clearly establish that the
presence of antioxidants in isolation and preservation media
detoxifies mitochondria-derived ROS and substantially improves
viability of islets and their potency to normalize blood glucose in
recipient diabetic animals [68]. Thus, these observations highlight
that the control of ROS release must be taken into account to
improve the preservation of islets in vitro.
Moreover, the delayed response of HO-1 and the low response
of IL-10 have led us to use mediators to limit pro-inflammatory
and pro-oxidant responses of islets. Our focus is due to the well
accepted benefits of HO-1 on islet survival and function [40] and
the fact that HO-1 mediates the anti-inflammatory effect of
interleukin-10 [69]. In this way the low level of IL-10 release by
islets could be induced by the up-regulation of HO-1. As suggested
by several papers, in order to optimize culture conditions,
enhancement of the expression of selected genes during culture
that may improve islet engraftment like HO-1 [40] or IL-10 [70] is
an efficient approach.
Several studies suggest that HO-1 could exert its anti-
inflammatory effect by an inhibition of TLR-4 up-regulation in
pancreatic islet [30]. TLR-4 is normally activated in islets during
the isolation procedure, and its activation initiates inflammation,
revealing the importance of the TLR-4 signaling pathway in the
context of islet transplantation. Indeed, it has been demonstrated
that islets express TLR-4 [31] and that TLR-4 mediates the early
graft failure following islet transplantation [31,71]. However, we
highlighted the importance of this receptor even before transplan-
tation. Given that we detected low levels of endotoxin (lower than
0.7 EU/ml), induction of the TLR signaling pathway was due to a
‘‘sterile inflammation’’. More precisely, it has been demonstrated
that TLRs can bind endogenous ligands, called Damage-
Associated Molecular Patterns (DAMPs). Thus, these ligands can
be generated by injury during pancreas conservation, islet isolation
or hypoxia during the time of culture. Some studies have suggested
that proteins generated by stressed islets like high mobility group
box 1 (HMGB1) or residues of digested extracellular matrix like
heparin sulfate [72], could be at the origin of this sterile
inflammation [73]. The identity of these factors could be
investigated in future studies.
Our results also showed that simultaneous inhibition of TLR-4
and induction of HO-1 are equally efficient in blocking COX2,
CCL2 and IL-6 activation as inhibition of TLR4 alone. Hence,
our data suggest that HO-1 is an upstream regulator of the TLR4
signaling pathway. In fact, HO-1 activation induced NFkB
activation. Several studies have already demonstrated that during
the inflammatory process, the increased of HO-1 expression was
correlated was the activation of NFkB [74]. However, while TLR-
4 inhibition has no effect on NFkB activation induced during islet
culture, co-treatment of islet with HO-1 activator and TLR-4
inhibitor significantly increased NFkB activation induced by
CoPP. These data suggested that HO-1 and TLR-4 could act in
a unique signaling pathway to induce the pro-inflammatory status
of islet.
To confirm this hypothesis, we studied the effect of HO-1
induction on TLR-4 activation using LPS. We then demonstrated
that TLR-4 activation was completely inhibited by HO-1
activation confirmed the relationship between HO-1 and TLR-4
signaling pathway on islet pro-inflammatory status.
However, the signaling pathway involved in the production
ROS seems to be different. Indeed, we observed a higher
inhibition of ROS production with the simultaneous TLR-4
inhibition and HO-1 activation. Our data suggest that ROS are
generated by two distinct pathways dependent on either HO-1 or
TLR-4. Thus, we have demonstrated that even if the regulation of
TLR-4 is dependent on HO-1 in the case of inflammatory
mediator generation such as COX-2, IL-6 and CCL2, it seems
that these signaling pathways act in an independent manner to
regulate the production of ROS.
In order to show the benefits brought by the inhibition of the
TLR-4 signaling pathway, we compared the recruitment of
peritoneal macrophages after induction with islet supernatant.
These cell culture supernatants were harvested 24 h after
treatment of islet. We demonstrated that the macrophage
chemotaxis was reduced by islet supernatant as previously
described [56]. The decrease of macrophages migration with
TLR-4 inhibition and HO-1 activation could be explained by the
decreased levels of secreted CCL-2. Our data are in agreement
with the study of Piemonti et al. suggesting that CCL-2 is the
major chemokine for monocytes in the supernatants of cultured
pancreatic islets [22].
In conclusion, we demonstrated that TLR-4 signaling pathway
plays a crucial role in the regulation of the pro-inflammatory and
pro-oxidant response of islet in vitro. It appears that pro-
inflammatory responses induced by TLR-4 can be inhibited by
HO-1 while the pro-oxidant response induced by TLR-4 seemed
independent. These data demonstrate unambiguously the impor-
tance of the TLR-4 signaling pathway in deleterious islet-
inflammation and characterize the well-known benefits of HO-1
on islet transplantation and may help to target new therapeutic
molecules that could protect islets before transplantation.
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